News
EQS-News: IVU.rail at Swiss Federal Railways (SBB)
Annual General Meeting 2025: Shareholders approve all proposals
Interactive Brokers Expands Access to Prediction Markets with Nearly 24/6 Trading
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the launch of expanded trading hours for Forecast Contracts. Eligible clients can now trade Forecast
Training Industry Selects FranklinCovey as a 2025 Top 20 Sales Training and Enablement Company
FranklinCovey (NYSE: FC), one of the largest and the most trusted leadership companies in the world, announced today it has been selected as a Training Industry 2025 Top 20 Sales Training and
Fuller, Smith & Turner PLC: Transaction in own shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
SoftwareOne reaches over 90% in Crayon at the end of the offer period
Eurofins Sustainability Services Introduces First Recycled Plastics Testing That Leverages Properties of Plastics for Accurate Results to Support Authenticity of Textile Claims
Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include recycled plastics
Willdan Expands and Extends Bank Credit Facilities
Willdan Group, Inc. (NASDAQ: WLDN) announced today that it has completed an amendment of its existing credit facilities to expand the available borrowing capacity and extend the term of the
Morgan Stanley Announces Children’s Mental Health Innovation Award Winners, Expands Program to Next Gen Leaders
Morgan Stanley today announced the 2025 winners of its Alliance for Children’s Mental Health (the “Alliance”) Innovation Awards, an initiative that aims to fund and advance transformative mental
FIGEAC AÉRO: 10 JUNE 2025: RELEASE OF FULL-YEAR 2024/25 RESULTS
FIGEAC AÉRO: 2024/25 REVENUE TARGET ACHIEVED: €432.3M, REFLECTING 8.1% ORGANIC GROWTH FINANCIAL PERFORMANCE TARGETS REITERATED
EQS-News: Aroundtown SA proactively manages debt maturity schedule through successful €750 million bond issuance and launch of buy back tender for bonds
EQS-News: Conference call on the results for the 2nd quarter 2024/2025 (ending 31 March 2025) on 15 May 2025
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2024
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2025
Velera Elevates Fraud Management and Cardholder Experience with FICO Platform
FICO (NYSE: FICO):
Highlights:
-
Velera uses FICO® Platform’s Omni-Channel Engagement Capability to modernize fraud alerting for its clients and their cardholders -
Achieved a 85% reduction in
UiPath Recognizes Fast Track Partners for Their Innovation with Agentic Automation
UiPath (NYSE: PATH), a global leader in agentic automation, today honored partners with a badge of distinction for being a UiPath Agentic Automation Fast Track Partner. This recognition is granted
Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced important derisking events in the pathway to a planned BLA submission for isaralgagene civaparvovec, or
OneSpan Announces Participation in Upcoming Investor Conferences
OneSpan Inc. (NASDAQ: OSPN), a leader in securing digital banking transactions and eSignatures, today announced that members of its management team will participate in the following investor
MaxLinear, Inc. Announces Second Quarter 2025 Financial Conference Participation
MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following financial
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced the appointment of Tim
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.
Bernard Zovighian, chief executive officer, and
Perion Announces Conference Participation in May 2025
Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, announced today that it will participate in the 20th Annual Needham